|
FR2409980A1
(fr)
*
|
1977-11-24 |
1979-06-22 |
Synthelabo |
Ethers de phenols et leur application en therapeutique
|
|
IT1147311B
(it)
*
|
1980-02-13 |
1986-11-19 |
Stabil Bioterapico Farmachim |
Eteri basici di 4-idrossi-benzofenoni con attivita' quali agenti betabloccanti e relativi procedimento di preparazione
|
|
ZW9881A1
(en)
*
|
1980-06-02 |
1981-12-23 |
Hoffmann La Roche |
Substituted phenoxyaminopropanol derivatives
|
|
DE3125870C2
(de)
*
|
1980-07-09 |
1994-09-15 |
William John Louis |
3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
|
|
CH643527A5
(en)
*
|
1980-10-24 |
1984-06-15 |
Ciba Geigy Ag |
Process for the preparation of 1-alkylamino-3-(4-(2-lower alkoxy-ethyl)phenoxy)-2-propanols
|
|
FI76551C
(fi)
|
1980-11-06 |
1988-11-10 |
Sandoz Ag |
Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-aminopropoxifenylderivat.
|
|
JPS57108047A
(en)
*
|
1980-11-06 |
1982-07-05 |
Sandoz Ag |
3-aminopropoxyphenyl derivative, manufacture and pharmaceutical composition containing same
|
|
US5347050A
(en)
*
|
1980-11-06 |
1994-09-13 |
Richard Berthold |
3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
|
|
DE3125636A1
(de)
*
|
1981-06-30 |
1983-01-13 |
Merck Patent Gmbh, 6100 Darmstadt |
1-(p-2-isopropoxyethoxymethyl-phenoxy)-3-isopropylamino-propan-2-ol zur senkung des augeninnendrucks und ophtalmikum, enthalten diese verbindung
|
|
FR2512443A1
(fr)
*
|
1981-09-10 |
1983-03-11 |
Synthelabo |
Derives de phenoxy-3 propanol-2, leur preparation et leur application en therapeutique
|
|
DE3151201A1
(de)
*
|
1981-12-23 |
1983-07-28 |
Beiersdorf Ag, 2000 Hamburg |
Substituierte phenoxyalkanolamine und phenoxyalkanol-cycloalkylamine, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische zubereitungen und zwischenprodukte
|
|
US4450172A
(en)
*
|
1982-03-10 |
1984-05-22 |
E. I. Du Pont De Nemours And Company |
Antihypertensive polyhalohydroxyisopropyl phenylalka(e)noic acid esters of alkylaminohydroxypropyloxyphenylalkyl alcohols
|
|
FR2536390B1
(fr)
*
|
1982-11-22 |
1986-03-21 |
Synthelabo |
Isomere s du betaxolol, sa preparation et son application en therapeutique
|
|
CA1262729A
(en)
*
|
1983-10-19 |
1989-11-07 |
Leo Alig |
Phenoxypropanolamines
|
|
US5166218A
(en)
*
|
1983-10-19 |
1992-11-24 |
Hoffmann-La Roche Inc. |
Phenoxypropanolamines and pharmaceutical compositions thereof
|
|
ZA852843B
(en)
*
|
1984-05-15 |
1985-11-27 |
Warner Lambert Co |
Bevantolol preparation
|
|
GB8412864D0
(en)
*
|
1984-05-19 |
1984-06-27 |
Smith Kline French Lab |
Chemical compounds
|
|
US5554367A
(en)
*
|
1984-10-31 |
1996-09-10 |
Alcon Laboratories, Inc. |
Compositions for treatment of glaucoma
|
|
ES8609190A1
(es)
*
|
1985-02-07 |
1986-07-16 |
Pharma Investi S A |
Un procedimiento para preparar eteres fenolicos
|
|
US5095151A
(en)
*
|
1985-05-21 |
1992-03-10 |
American Home Products Corporation |
Preparation of propranolol hydrochloride macrocrystals
|
|
EP0252007A3
(en)
*
|
1986-06-28 |
1989-07-05 |
Ciba-Geigy Ag |
2-propanol derivatives as corrosion inhibitors
|
|
US4694022A
(en)
*
|
1986-12-24 |
1987-09-15 |
Alcon Laboratories, Inc. |
Fatty acid salts of betaxolol useful in the treatment of glaucoma
|
|
DE3866984D1
(en)
*
|
1987-07-21 |
1992-01-30 |
Hoffmann La Roche |
Phenoxypropanolamine.
|
|
FR2672594B1
(fr)
*
|
1991-02-08 |
1994-07-01 |
Synthelabo |
Derives d'ethers de phenols, leur preparation et leur application en therapeutique.
|
|
JP4241926B2
(ja)
*
|
1995-10-10 |
2009-03-18 |
ウィリアム ジョン ルイス |
３―アミノ―プロポキシフェニル誘導体（１）
|
|
CA2193149C
(en)
*
|
1995-12-22 |
2002-04-23 |
David H. Donabedian |
Cationic therapuetic agents and delivery systems
|
|
US5942633A
(en)
*
|
1996-06-19 |
1999-08-24 |
Abbott Laboratories |
Process for the selective alkylation of betaxolol intermediates
|
|
US5731463A
(en)
*
|
1996-09-23 |
1998-03-24 |
Abbott Laboratories |
Selective alkylation of an alcohol substituted phenol compound
|
|
DE69942578D1
(de)
|
1998-05-22 |
2010-08-26 |
Univ R |
Bifunktionelle moleküle sowie darauf basierende therapien.
|
|
US6258350B1
(en)
|
1999-01-20 |
2001-07-10 |
Alcon Manufacturing, Ltd. |
Sustained release ophthalmic formulation
|
|
CA2388728C
(en)
*
|
1999-11-30 |
2009-05-19 |
Alcon Inc. |
Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina
|
|
ATE330633T1
(de)
*
|
2000-07-27 |
2006-07-15 |
Pharmacia Corp |
Epoxy-steroidaler aldosteronantagonist und beta- adrenergischer antagonist-kombinationstherapie zur behandlung von kongestivem herzversagen
|
|
CA2450073C
(en)
|
2001-07-25 |
2017-08-29 |
Biomarin Pharmaceutical Inc. |
Compositions and methods for modulating blood-brain barrier transport
|
|
US7001615B1
(en)
|
2001-12-07 |
2006-02-21 |
Alcon, Inc. |
Sustained release ophthalmic, otic and nasal suspension
|
|
AP2005003232A0
(en)
|
2002-08-19 |
2005-03-31 |
Pfizer Prod Inc |
Combination therapy for hyperproliferative diseases.
|
|
AU2004242777B2
(en)
*
|
2003-05-30 |
2011-05-12 |
Ranbaxy Laboratories Limited |
Substituted pyrrole derivatives and their use as HMG-Co inhibitors
|
|
CN1300079C
(zh)
*
|
2004-12-03 |
2007-02-14 |
南京大学 |
合成4－[2－(环丙基甲氧基)乙基]苯酚的新工艺
|
|
JP2008539047A
(ja)
|
2005-04-28 |
2008-11-13 |
プロテウス バイオメディカル インコーポレイテッド |
ファーマインフォーマティックスシステム
|
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
|
SG166829A1
(en)
*
|
2005-11-08 |
2010-12-29 |
Ranbaxy Lab Ltd |
Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
|
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
|
CL2007000667A1
(es)
*
|
2006-03-14 |
2008-03-14 |
Ranbaxi Lab Ltd |
Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
|
|
EP2049102A4
(en)
*
|
2006-07-14 |
2010-12-22 |
Ranbaxy Lab Ltd |
POLYMORPHIC FORMS OF AN HMG COA REDUCTASE HEATHER AND USE
|
|
US20080161324A1
(en)
*
|
2006-09-14 |
2008-07-03 |
Johansen Lisa M |
Compositions and methods for treatment of viral diseases
|
|
CN101594878A
(zh)
|
2006-09-18 |
2009-12-02 |
雷普特药品公司 |
通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗
|
|
US8404896B2
(en)
|
2006-12-01 |
2013-03-26 |
Bristol-Myers Squibb Company |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
|
|
CA2679263A1
(en)
|
2007-02-28 |
2008-09-04 |
Asahi Kasei Pharma Corporation |
Sulfonamide compound
|
|
US9782488B2
(en)
*
|
2007-03-12 |
2017-10-10 |
Nektar Therapeutics |
Oligomer-beta blocker conjugates
|
|
EP2050441A1
(en)
|
2007-10-19 |
2009-04-22 |
Université Victor Segalen Bordeaux 2 |
Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas
|
|
US8987262B2
(en)
|
2007-10-19 |
2015-03-24 |
Universite de Bordeaux |
Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
|
|
JP2009040769A
(ja)
*
|
2008-07-09 |
2009-02-26 |
William John Louis |
３−アミノ−プロポキシフェニル誘導体（ｉ）
|
|
EP3395372B1
(en)
|
2009-02-20 |
2022-04-06 |
EnhanX Biopharm Inc. |
Glutathione-based drug delivery system
|
|
SG10201402069PA
(en)
|
2009-05-06 |
2014-07-30 |
Lab Skin Care Inc |
Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
|
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
|
MX2015014666A
(es)
|
2013-04-17 |
2016-03-01 |
Pfizer |
Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares.
|
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
|
AU2020209215B2
(en)
|
2019-01-18 |
2023-02-02 |
Astrazeneca Ab |
PCSK9 inhibitors and methods of use thereof
|